Anti-VEGF Treatment Strategies for Wet AMD
oleh: Jaclyn L. Kovach, Stephen G. Schwartz, Harry W. Flynn, Ingrid U. Scott
| Format: | Article |
|---|---|
| Diterbitkan: | Wiley 2012-01-01 |
Deskripsi
Over the past few years, antivascular endothelial growth factor (VEGF) therapy has become a standard treatment for neovascular age-related macular degeneration (AMD). During this time, treatment strategies have evolved from a monthly dosing schedule to individualized regimens. This paper will review the currently available anti-VEGF agents and evidence-based treatment strategies.